Home › NDC Lookup › RxCUI directory › RxCUI 2049730

Pasireotide 30 MG Injection — RxCUI 2049730

Name: Pasireotide 30 MG Injection (RxCUI 2049730)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2049730 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2049730

Official namePasireotide 30 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspasireotide LAR (as pasireotide pamoate) 30 MG Injection; pasireotide LAR 30 MG Injection

FDA products mapped5

Package NDCs mapped5

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pasireotide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Signifor LAR treats acromegaly and Cushing's disease. It is for people whose surgery did not work well enough or is not possible. It lowers the excess hormones behind these conditi...
A trained health care professional mixes it and injects it into your buttock muscle, usually every 4 weeks. You don't give it yourself, and food doesn't matter.
Diarrhea, nausea, belly pain, headache, tiredness, and hair loss are common. High blood sugar and gallstones are also common, so you'll be monitored.
Call about extreme thirst or urination, fainting, a very slow or irregular heartbeat, severe belly pain or fever, yellowing skin, severe weakness, or greasy loose stools.

📖 Read our full Pasireotide Injection guide →

🕸️ Concept Web — How Pasireotide 30 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Pasireotide 30 MG Injection RxCUI 2049730 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Pasireotide 1364105 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Signifor 1364110 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pasireotide Injection 1655405 SCDF
- Pasireotide Injectable Product 1421174 SCDG
- Pasireotide Injection [Signifor] 1655407 SBDF
- Signifor Injectable Product 1364113 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pasireotide 30 MG 2049729 SCDC
- Pasireotide 30 MG Injection [Signifor] 2049732 SBD
- Pasireotide 30 MG [Signifor] 2049731 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pasireotide 30 MG SCDC · 2049729
Pasireotide Injection SCDF · 1655405
Pasireotide Injectable Product SCDG · 1421174

Brand-Name Concepts

Pasireotide 30 MG Injection [Signifor] SBD · 2049732
Pasireotide 30 MG [Signifor] SBDC · 2049731
Pasireotide Injection [Signifor] SBDF · 1655407
Signifor Injectable Product SBDG · 1364113
Signifor BN · 1364110

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 2049730 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55292-0139-01	1 KIT in 1 KIT (55292-139-01) * 6 mL in 1 VIAL, SINGLE-USE...	Signifor LAR	Recordati Rare Diseases, Inc.	2018-06-29
55292-0140-01	1 KIT in 1 KIT (55292-140-01) * 6 mL in 1 VIAL, SINGLE-USE...	Signifor LAR	Recordati Rare Diseases, Inc.	2014-12-15
55292-0141-01	1 KIT in 1 KIT (55292-141-01) * 6 mL in 1 VIAL, SINGLE-USE...	Signifor LAR	Recordati Rare Diseases, Inc.	2018-06-29
55292-0142-01	1 KIT in 1 KIT (55292-142-01) * 6 mL in 1 VIAL, SINGLE-USE...	Signifor LAR	Recordati Rare Diseases, Inc.	2014-12-15
55292-0143-01	1 KIT in 1 KIT (55292-143-01) * 6 mL in 1 VIAL, SINGLE-USE...	Signifor LAR	Recordati Rare Diseases, Inc.	2014-12-15

Observed labelers: Recordati Rare Diseases, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2502	Inj, pasireotide long acting	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.